Key result
Continued anticoagulation after percutaneous left atrial appendage ligation showed no difference in rates of thromboembolic events, bleeding, and mortality compared to no anticoagulation over 60 months.
May support discontinuing anticoagulation after LAA ligation; leaves open confirmation in randomized trials.
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Undas A. Adverse outcomes in anticoagulated patients undergoing percutaneous left atrial appendage ligation. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2020;16(2):231-232. doi:10.5114/aic.2020.96075. APA Undas, A. (2020). Adverse outcomes in anticoagulated patients undergoing percutaneous left atrial appendage ligation. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 16(2), 231-232. https://doi.org/10.5114/aic.2020.96075 Chicago Undas, Anetta. 2020. "Adverse outcomes in anticoagulated patients undergoing percutaneous left atrial appendage ligation". Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej 16 (2): 231-232. doi:10.5114/aic.2020.96075. Harvard Undas, A. (2020). Adverse outcomes in anticoagulated patients undergoing percutaneous left atrial appendage ligation. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, 16(2), pp.231-232. https://doi.org/10.5114/aic.2020.96075 MLA Undas, Anetta. "Adverse outcomes in anticoagulated patients undergoing percutaneous left atrial appendage ligation." Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej, vol. 16, no. 2, 2020, pp. 231-232. doi:10.5114/aic.2020.96075. Vancouver Undas A. Adverse outcomes in anticoagulated patients undergoing percutaneous left atrial appendage ligation. Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej. 2020;16(2):231-232. doi:10.5114/aic.2020.96075.
No takes yet. Share an insight, caveat, or question.
Anetta Undas (2020) conducted a letter in Atrial fibrillation (n=139). Continued anticoagulation after LAA ligation vs. No anticoagulation was evaluated on Thromboembolic events, bleeding events, and mortality. Continued anticoagulation after percutaneous left atrial appendage ligation showed no difference in rates of thromboembolic events, bleeding, and mortality compared to no anticoagulation over 60 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: